Inventor · disambiguated record
Vadim Markovtsov
Also filed as: MARKOVTSOV VADIM · MARKOVTSOV VADIM M V
12 granted patents·5 pending applications·212 citations·filing 2003–2022
91Inventor score
Top patents by PatentIndex Score
17 records- 0197US7834024B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Nov 16, 2010·59 cites·6 claims
- 0296US7947698B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted May 24, 2011·55 cites·54 claims
- 0396US7754714B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·39 cites·24 claims
- 0493US8299087B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2010·Granted Oct 30, 2012·11 cites·4 claims
- 0590US8304422B2Compositions and methods for inhibition of the JAK pathwayATUEGBU ANDY·Filed 2010·Granted Nov 6, 2012·26 cites·22 claims
- 0689US8410093B2Cycloalkyl substituted pyrimidinediamine compounds and their usesLI HUI·Filed 2010·Granted Apr 2, 2013·9 cites·20 claims
- 0787US9725419B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Aug 8, 2017·7 cites·3 claims
- 0879US8846908B2Tricyclic carbamate JAK inhibitorsSINGH RAJINDER·Filed 2009·Granted Sep 30, 2014·3 cites·24 claims
- 0975US9005909B2Whole blood assay for measuring AMPK activationMARKOVTSOV VADIM·Filed 2011·Granted Apr 14, 2015·3 cites·16 claims
- 1061US9624229B2Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinasesRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Apr 18, 2017·0 cites·8 claims
- 1160US2024382470A1Irak Inhibitor for Treating Cytokine Release-Related Conditions Associated With Infection by a Respiratory VirusRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1258US12263180B2Method for treatment of COVID-19-associated conditionsRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Apr 1, 2025·0 cites·39 claims
- 1356US9383362B2Whole blood assay for measuring AMPK activationRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Jul 5, 2016·0 cites·22 claims
- 1454US2014363443A1Tricyclic carbamate jak inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1548US2015087673A1Methods for using and biomarkers for ampk-activating compoundsHITOSHI YASUMICHI·Filed 2014·Application pending·0 cites
- 1643US2022000880A1Method and composition embodiments for treating acute myeloid leukemiaRIGEL PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1742US2004126784A1Modulators of cellular proliferationRIGEL PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vadim Markovtsov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →